LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

Kodu・Aktsiate loetelu・Medtronic PLC

Search

Medtronic PLC

Avatud

SektorTervishoid

74.57 -1.3

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

74.73

Max

75.82

Põhinäitajad
By Trading Economics
Sissetulek	-231M 1.1B
Müük	57M 9B
P/E Sektori keskmine	21.955 50.102
Aktsiakasum	1.36
Dividenditootlus	3.62
Kasumimarginaal	12.675
Töötajad	95,000
EBITDA	124M 2.5B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+38.04% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	3.62% 2.33%
Järgmine tulemuste avaldamine	3. juuni 2026
Järgmine dividendimakse kuupäev	10. juuli 2026
Järgmine aktsia dividendi kuupäev (ex-date)	26. juuni 2026

Turustatistika
By TradingEconomics
Turukapital	-27B 101B
Eelmine avamishind	75.87
Eelmine sulgemishind	74.57

Uudiste sentiment

By Acuity

36%

64%

95 / 344 Pingereas Healthcare

Medtronic PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. mai 2026, 13:49 UTC

Omandamised, ülevõtmised, äriostud

Medtronic to Buy SPR Therapeutics for About $650 Million

10. märts 2026, 11:19 UTC

Omandamised, ülevõtmised, äriostud

Medtronic to Buy Scientia Vascular in $550 Million Deal

17. veebr 2026, 12:43 UTC

Tulu

Medtronic 3Q Profit Falls Despite Higher Revenue

20. mai 2026, 13:15 UTC

Omandamised, ülevõtmised, äriostud

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20. mai 2026, 13:15 UTC

Omandamised, ülevõtmised, äriostud

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22. apr 2026, 11:27 UTC

Tulu

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20. apr 2026, 11:50 UTC

Omandamised, ülevõtmised, äriostud

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24. märts 2026, 20:59 UTC

Tulu

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10. märts 2026, 10:46 UTC

Omandamised, ülevõtmised, äriostud

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10. märts 2026, 10:46 UTC

Omandamised, ülevõtmised, äriostud

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10. märts 2026, 10:45 UTC

Omandamised, ülevõtmised, äriostud

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10. märts 2026, 10:45 UTC

Omandamised, ülevõtmised, äriostud

Medtronic to Acquire Scientia Vascular >MDT

17. veebr 2026, 21:21 UTC

Tulu

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17. veebr 2026, 18:11 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 14:48 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 13:00 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 12:05 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 11:47 UTC

Tulu

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17. veebr 2026, 11:47 UTC

Tulu

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17. veebr 2026, 11:46 UTC

Tulu

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17. veebr 2026, 11:46 UTC

Tulu

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17. veebr 2026, 11:46 UTC

Tulu

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Adj EPS $1.36 >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Sales $9.02B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Diabetes Rev $796M >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Net $1.14B >MDT

Võrdlus sarnastega

Hinnamuutus

Medtronic PLC Prognoos

Hinnasiht

By TipRanks

38.04% tõus

12 kuu keskmine prognoos

Keskmine 104.88 USD 38.04%

Kõrge 120 USD

Madal 84 USD

Põhineb 18 Wall Streeti analüütiku instrumendi Medtronic PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

18 ratings

11

Osta

7

Hoia

0

Müü

Põhineb 18 analüütiku instrumendi Medtronic PLC aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

95 / 344 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

1,094.64

JNJ

Johnson and Johnson

227.39

ABBV

AbbVie Inc

217.23

UNH

UnitedHealth Group Inc

377.5

MRK

Merck & Co Inc.

118.74

Live chat